Clinical TrialsSearch results
Number of results: 2510
Not yet recruiting
- A study to test the effects and safety of riliprubart in people with chronic inflammatory demyelinating polyneuropathy (CIDP) for which the usual treatments do not work
- chronic inflammatory demyelinating polyneuropathy
- Tanaka Tomoyuki
- 2024-05-24
Not yet recruiting
- A multicentre, randomised, double-blind, placebo-controlled, parallel-group, investigators initiated phase III clinical trial to evaluate the efficacy of IDEC-C2B8 in patients with steroid treatment-resistant bullous pemphigoid.
- bullous pemphigoid
- Takahashi Hayato
- 2024-05-24
Recruiting
- Prospective randomised clinical trial on the impact of nutritional guidance on patients with acute myocardial infarction
- Acute myocardial infarction
- Miyazaki Tetsuro
- 2024-05-24
Recruiting
- A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
- Advanced Solid Tumors
- Iizumi Sakura
- 2024-05-24
Other
- A safety epidemiological study assessing the effect of Daikenchuto (TJ-100) on the risk of liver injury in cancer patients who underwent colectomy or gastrectomy
- stomach cancer
- asakawa takeshi
- 2024-05-22
Not yet recruiting
- A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)
- Amyotrophic Lateral Sclerosis in patients with FUS-ALS
- Rebecca Crean
- 2024-05-22
Recruiting
- Feasibility test for continuous measurement of skin resistance
- sebum deficiency
- Ito Yoshihiro
- 2024-05-21
Recruiting
- Evaluation of the usefulness of oral health support programs for local residents
- Oral health issues in general
- Yamaura Katsunori
- 2024-05-20
Recruiting
- A Randomised, Open-Label, Phase III Study of Saruparib (AZD5305) Plus Camizestrant Compared With Physician's Choice CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant for the First-Line Treatment of Patients With BRCA1, BRCA2, or PALB2 Mutations and Hormone Receptor Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified) Advanced Breast Cancer (EvoPAR-Breast01)
- Advanced Breast Cancer
- Hibi Kazushige
- 2024-05-20
Not yet recruiting
- OPT Study
- Severe asthma
- Masaki Katsunori
- 2024-05-17